New Delhi: Redcliffe Labs and Skyroot Aerospace have joined hands to explore the future of diagnostics in space through DRIFT-1, bringing together India’s diagnostics and private space capabilities in a collaboration focused on studying how diagnostic reagents perform in Low Earth Orbit (LEO).
The collaboration marks an initiative connecting India’s healthcare and private space ecosystems. Through DRIFT-1, Redcliffe Labs’ dry diagnostic reagents will be placed in Low Earth Orbit for 90 days alongside an identical ground control.
The comparison is intended to help establish how the space environment affects the stability and performance of the reagents while generating a flight-heritage dataset for the technology.
DRIFT-1 to Test Diagnostic Reagents in Low Earth Orbit
The first step of the collaboration, DRIFT-1, will test Redcliffe Labs’ dry diagnostic reagents in Low Earth Orbit for 90 days. An identical set will be maintained on the ground as a control for comparison.
The data generated through DRIFT-1 will help assess the impact of the space environment on reagent stability and performance.
The initiative is also expected to generate data that could help inform the development of more resilient diagnostic solutions for challenging environments on Earth.
The collaboration combines Redcliffe Labs’ expertise in diagnostics with Skyroot Aerospace’s capabilities in space technology.
The companies aim to study how diagnostic technologies perform under the extreme conditions of Low Earth Orbit and explore how the findings could contribute to diagnostics on Earth.
Collaboration Explores Future Space Diagnostics
Beyond DRIFT-1, the collaboration has potential applications across space-enabled diagnostics, astronaut health, life sciences and microgravity research.
The initiative could also contribute to the development of future point-of-care diagnostic solutions for human spaceflight, including potential applications for Gaganyaan and the Bharatiya Antariksh Station.
For Redcliffe Labs, the opportunity is focused on converting the data generated through DRIFT-1 into knowledge that can inform more resilient diagnostic technologies for challenging environments on Earth.
Such applications could include settings where conventional healthcare infrastructure or cold-chain availability is limited.
Also Read: India Payments Landscape: UPI Ecosystem Draws $5.8 Billion in Funding, Led by Consumer Apps
Redcliffe Labs Chairman Dheeraj Jain on DRIFT-1
Dheeraj Jain, Chairman & Co-Founder, Redcliffe Labs, said, “The most transformative breakthroughs often happen at the intersection of disciplines that rarely come together.
By bringing together Redcliffe Labs’ expertise in diagnostics and Skyroot Aerospace’s leadership in space technology, we are opening a new frontier for scientific research and innovation.
More importantly, this partnership reflects the growing confidence that India’s scientific and innovation ecosystem can bring together diverse capabilities to solve complex global challenges.”
The DRIFT-1 initiative reflects the companies’ focus on bringing together different areas of scientific and technological expertise to explore new applications for diagnostics.
Aditya Kandoi on Taking Diagnostics Beyond the Conventional Laboratory
Aditya Kandoi, Founder & CEO, Redcliffe Labs, commented, “Space is one of the most demanding environments in which to test any technology, making it an extraordinary laboratory for innovation in diagnostics.
Through this collaboration, we are taking our scientific expertise beyond the conventional laboratory to understand how our diagnostic technologies perform in orbit, with the ambition of bringing those learnings back to Earth.
If we can build diagnostics that withstand the rigours of space, we can create more resilient technologies that improve access to reliable healthcare in some of the most challenging environments on Earth.”
Through DRIFT-1, Redcliffe Labs will study the performance of its dry diagnostic reagents in orbit while comparing them against an identical ground control.
The resulting data is intended to support further understanding of diagnostic technology performance under challenging environmental conditions.
Skyroot Aerospace CEO Pawan Kumar Chandana on the Partnership
Pawan Kumar Chandana, Co-Founder & CEO, Skyroot Aerospace, added, “A diagnostics leader taking its expertise to orbit is exactly the kind of use case we want to open up by opening space for all. Skyroot’s partnership with Redcliffe Labs is a first step towards keeping astronauts healthier in orbit.”
The collaboration positions DRIFT-1 as the first step in a broader exploration of the role that diagnostics could play in space environments, including applications related to astronaut health and human spaceflight.
Redcliffe Labs’ Focus on Diagnostics, Technology and Research
For Redcliffe Labs, the DRIFT-1 collaboration forms part of its long-term strategy of combining diagnostics, technology and scientific research to shape the future of healthcare.
As the company expands beyond diagnostics services into advanced research and development and life sciences innovation, initiatives such as DRIFT-1 reinforce its focus on creating differentiated technologies aimed at improving healthcare outcomes and adding healthy years to lives.
The collaboration with Skyroot Aerospace brings together diagnostic science and space technology to examine how diagnostic reagents perform in Low Earth Orbit and how the resulting learnings could support the development of more resilient diagnostic technologies for use on Earth.
